Moderna | MRNA - Current Liabilities


Moderna reported $2.03B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 332.22M 29.22M Sep/2026
Agios Pharmaceuticals USD 77.59M 7.37M Sep/2026
Alnylam Pharmaceuticals USD 2.06B 550.49M Sep/2026
Amgen USD 23.23B 2.27B Sep/2026
Arrowhead Research USD 311.34M 27.99M Sep/2026
Biogen USD 3.9B 18.7M Sep/2026
BioMarin Pharmaceutical USD 1.6B 59.17M Sep/2026
Celltrion KRW 288.01B 4.7B Jun/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 28.51M 5.87M Sep/2026
Divis Laboratories Ltd INR 27.07B 6.64B Sep/2026
Gilead Sciences USD 12B 982M Sep/2026
GlaxoSmithKline GBP 20.72B 814M Sep/2026
Incyte USD 1.44B 125.72M Sep/2026
Ionis Pharmaceuticals USD 435.29M 119.65M Sep/2026
Kangmei Pharma CNY 5.1B 280.48M Jun/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Malin Corporation EUR 1000K 500K Dec/2024
Moderna USD 2.03B 506M Sep/2026
Organigram Holdings CAD 107.28M 18.54M Jun/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pharma Mar EUR 125.39M 26.97M Sep/2026
Puma Biotechnology USD 82.73M 3.63M Sep/2025
Qiagen NV USD 581.45M 102.34M Jun/2026
Regeneron Pharmaceuticals USD 6.2B 671.5M Sep/2026
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sarepta Therapeutics USD 656.35M 153.44M Sep/2026
Sartorius EUR 1.55B 102.8M Sep/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tilray USD 259.32M 8.32M Sep/2025
Ultragenyx Pharmaceutical USD 389M 38M Sep/2026
United Therapeutics USD 624.3M 16.5M Sep/2026
Vertex Pharmaceuticals USD 5B 1.06B Sep/2026
Zealand Pharma A/S 404M 260.96M Mar/2026
Zz Pientze Pharmaceu CNY 2.74B 277.02M Sep/2026